-
Agamod subcutaneous injection approved in Japan for the treatment of systemic myasthenia gravis
According to the official WeChat account of Zaiding Pharmaceuticals, on January 18th, Zaiding Pharmaceuticals partner Argenx announced that the Japanese Ministry of Health, Labour and Welfare has app ... -
Pfizer subcutaneous injection of BCMA × CD3 dual antibody is proposed to be included in CDE priority evaluation
On January 31st, the official website of the Drug Evaluation Center (CDE) of the National Medical Products Administration announced that Pfizer has submitted an application for the marketing of Elana ...